- Home
- OCGN vs ICG Comparison
OCGN vs ICG Comparison
Compare OCGN & ICG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- ICG
- Stock Information
- Founded
- OCGN 2013
- ICG 2017
- Country
- OCGN United States
- ICG China
- Employees
- OCGN N/A
- ICG N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- ICG Semiconductors
- Sector
- OCGN Health Care
- ICG Technology
- Exchange
- OCGN Nasdaq
- ICG Nasdaq
- Market Cap
- OCGN 229.2M
- ICG 244.7M
- IPO Year
- OCGN N/A
- ICG 2023
- Fundamental
- Price
- OCGN $0.68
- ICG $4.00
- Analyst Decision
- OCGN Strong Buy
- ICG Strong Buy
- Analyst Count
- OCGN 3
- ICG 1
- Target Price
- OCGN $6.00
- ICG $11.00
- AVG Volume (30 Days)
- OCGN 3.5M
- ICG 18.5K
- Earning Date
- OCGN 03-05-2025
- ICG 02-27-2025
- Dividend Yield
- OCGN N/A
- ICG N/A
- EPS Growth
- OCGN N/A
- ICG N/A
- EPS
- OCGN N/A
- ICG 0.11
- Revenue
- OCGN $4,700,000.00
- ICG $34,648,799.00
- Revenue This Year
- OCGN N/A
- ICG N/A
- Revenue Next Year
- OCGN N/A
- ICG $74.94
- P/E Ratio
- OCGN N/A
- ICG $35.95
- Revenue Growth
- OCGN N/A
- ICG 202.16
- 52 Week Low
- OCGN $0.64
- ICG $2.80
- 52 Week High
- OCGN $2.11
- ICG $12.04
- Technical
- Relative Strength Index (RSI)
- OCGN 40.75
- ICG 44.87
- Support Level
- OCGN $0.67
- ICG $3.80
- Resistance Level
- OCGN $0.76
- ICG $4.19
- Average True Range (ATR)
- OCGN 0.04
- ICG 0.22
- MACD
- OCGN 0.00
- ICG 0.01
- Stochastic Oscillator
- OCGN 28.57
- ICG 39.74
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About ICG Intchains Group Limited
Intchains Group Ltd provides integrated solutions consisting of high-performance ASIC chips and ancillary software and hardware for blockchain applications. Its ASIC chips are designed for several key blockchain algorithms including Blake2bsha3, sha512MD160, Cryptonight V4, Eaglesong, Blake2s and others. The company has built a proprietary technology platform named Xihe Platform, which allows the development of a wide range of ASIC chips with high efficiency and scalability. It designs its ASIC chips in-house, which enables it to leverage proprietary silicon data to deliver products reflecting the latest technological developments.